Heart Failure And Cyanosis In Children Acyanotic And Cyanotic Congenital Heart Disease - Part 1

Congenital heart diseases are classified as acyanotic lesions (e.g., VSD, ASD, PDA) with left-to-right shunts causing heart failure, and cyanotic lesions (e.g., Tetralogy of Fallot, TGA) with right-to-left shunts producing systemic desaturation and cyanosis.

Heart Failure in Children: Acyanotic & Cyanotic Congenital Heart Disease — Part 1

1. The Concept of Paediatric Heart Failure

2. Clinical Presentation: How Do Infants and Children with Heart Failure Present?

2.2 Signs (Physical Examination)

The lecture categorises signs into three groups: [1]

3. Causes of Paediatric Heart Failure — Organised by Age

This is the core organisational framework of the lecture. The aetiology differs dramatically by age:

3.2 Left Ventricular Outflow Tract (LVOT) Obstruction — In Detail

This section is extensively covered in the lecture and is extremely high-yield.

1) Coarctation or interruption of the aorta — 2) Critical aortic stenosis — 3) Aortic atresia (hypoplastic left heart syndrome) [1]

3.4 Heart Failure in Infants (Weeks to Months of Life)

Large left-to-right shunts: Ventricular septal defect, Atrioventricular septal defect, Persistent arterial duct [1]

Later onset of symptoms (as compared to left ventricular outflow obstructive lesions) [1]

Why is the onset later?

  • At birth, pulmonary vascular resistance (PVR) is high (similar to systemic vascular resistance) → even with a structural defect allowing communication between systemic and pulmonary circulations, there is little net shunt.
  • Over the first 2–3 months of life, PVR falls physiologically (as the thick-walled fetal pulmonary arterioles remodel) → the pressure difference between the systemic and pulmonary circuits widens → blood shunts left-to-right through the defect → pulmonary overcirculation → heart failure symptoms emerge.
  • This is why babies with large VSDs or PDAs typically present at 6–8 weeks of age with symptoms of heart failure, not at birth.

4. Management of Paediatric Heart Failure

1) Identification of the cause and precipitating factors — 2) Tackling of precipitating factors — 3) General supportive management — 4) Medical therapy of heart failure (diuretics, digoxin, ACEI, carvedilol) — 5) Treatment of underlying cause, if possible, by surgical or catheter intervention — 6) Mechanical circulatory support and heart transplantation [1]

4.4 Mechanical Circulatory Support

6. Exam Intelligence

On this page

No Headings